| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |